Research Article: Decitabine-based treatment strategy improved the outcome of HSCT in JMML: a retrospective cohort study
Abstract:
Introduction: Pre-HSCT disease control, suboptimal long-term prognosis, and a high recurrence incidence (RI) continue to pose significant challenges for hematopoietic stem cell transplantation (HSCT) in juvenile myelomonocytic leukemia (JMML) patients.
No summary available.